 CHARLOTTESVILLE, Va., May 10, 2021 GLOBE NEWSWIRE -- Diffusion Pharmaceuticals Inc. NASDAQ: DFFN Diffusion or the Company, an innovative biopharmaceutical company developing novel therapies that enhance the bodys ability to deliver oxygen to areas where it is needed most, today announced financial results for the first quarter of 2021 and provided a business update. 